| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NONE | Common Stock | Award | $0 | +40.9K | +1.89% | $0.00 | 2.21M | 29 May 2024 | Direct | F1, F2 |
| holding | NONE | Common stock | 30K | 29 May 2024 | Held by ICCA Labs, LLC | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest on February 1, 2024 and each month thereafter, subject to the Reporting Person's continuous service through each such vesting date. |
| F2 | Includes 86,554 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
| F3 | Represents shares of the Issuer's common stock underlying 89,880 CDIs. |
| F4 | The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |